Silver Point Capital’s iTeos Therapeutics ITOS Stock Holding History

Silver Point Capital’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-290,000	Closed	-$2.89M	–	24
2025 Q2	$2.89M	Buy	+290,000	New	+$2.34M	0.2%	15

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Silver Point Capital's ITOS Position: Q3 2025 in Review

Silver Point Capital sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 290,000 shares — an estimated $2.89M sold.

Silver Point Capital first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $2.89M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Silver Point Capital reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Silver Point Capital sold 290,000 iTeos Therapeutics shares in Q3 2025, an estimated $2.89M.
Silver Point Capital first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
Silver Point Capital's iTeos Therapeutics position peaked at $2.89M in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Silver Point Capital's 13F filing for Q3 2025, filed 14 Nov 2025.